BridgeBio Oncology Therapeutics Inc.
BBOTBridgeBio Oncology Therapeutics Inc.
NASDAQ
Healthcare
Biotechnology
$8.92
-0.11(-1.2%)
52W $8.68 – $13.73
Quick:
8-K
Mar 26, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 5, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 5, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 7, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 13, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 12, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Sep 3, 2025 (7 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
S-1
Aug 29, 2025 (7 months ago)Registration Statement
IPO or secondary offering
Pricing, dilution, use of proceeds
SCHEDULE 13D
Aug 18, 2025 (7 months ago)SCHEDULE 13D
SEC filing disclosure
Filing details and context
SCHEDULE 13G
Aug 18, 2025 (7 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Aug 13, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Aug 13, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 6, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 4, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 1, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G/A
Jul 30, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Jul 24, 2025 (8 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jul 11, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction